Patient Centric Sampling (PCS)
What it is and how its implementation may be of benefit for biobanking?
The Patient Centric Sampling Interest Group (PCSIG) hosted an in-person workshop and presented a poster at the International Society for Biological and Environmental Repositories (ISBER) event in St. Petersburg, Florida, USA (5-6 November 2024).
This workshop introduced participants to patient centric sampling as a means of collecting human biological samples as an alternative to standard phlebotomy. It highlighted the technologies that are available for this approach, how they might benefit biobanking and what the challenges are for their use. A group discussion enabled participants to consider the benefits and challenges for implementation of PCS for biobanking.
Workshop Outline
-
Introduction to Patient Centric Sampling – Jeremiah Tipton, Ph.D. (Applied Omics & Life Science LLC )
-
Introduction to Patient Centric Sampling Interest Group
-
Current technologies and microsample devices
-
Benefit to the the general community
-
Challenges for implementation
-
Possible benefits to the biobanking community
-
-
Adding internal standards prior to blood collection for improved quantitative performance in dried blood spots Tim Garrett, Ph.D. (University of Florida, Gainesville, FL)
-
Application - Quantitative dried blood spots for amino acids and acylcarnitine with LC-MS/MS
-
Discuss on adding internal standardization prior to blood collection
-
Discussion on results correction for extraction efficiency and degradation
-
Possible benefits to the biobanking community
-
-
Workshop and Group Discussion
-
What information does the biobanking community need with regards to microsampling
-
How does patient centric sampling approaches benefit to the biobanking community
-
What are the challenges to implementation
-
How these challenges might be overcome
-
Poster Outline
The poster is designed as an introduction to the Patient Centric Sampling Interest Group (PCSIG) and a discussion on possible synergies with the biobanking community. It highlights the technologies that are available for this approach, how they might benefit biobanking, and what the challenges are for their use. The poster also introduces ISBER conference participants to PCS as a means of collecting high quality, human biological samples - as an alternative to standard phlebotomy practices.